Central China New Life Ltd represents a strong set of values and corporate philosophy. The company believes in integrity, transparency, and sustainable growth. With a focus on providing high-quality products and exceptional customer service, Central China New Life Ltd aims to create long-term value for its stakeholders. The company prioritizes innovation and constantly strives to meet changing market demands. Central China New Life Ltd is committed to operating ethically and nurturing a positive corporate culture that encourages teamwork and personal development. By aligning its actions with its core values, the company aims to build trust and deliver superior results for its investors and customers.

Central China New Life Ltd is primarily present in China.

Central China New Life Ltd has achieved several significant milestones in its history. One notable accomplishment was the successful launch of its innovative healthcare products, addressing the growing demand for affordable and high-quality medical solutions. Additionally, the company expanded its operations and established a strong presence in multiple international markets, boosting its global reach and market share. Furthermore, Central China New Life Ltd has received recognition for its commitment to research and development, constantly introducing cutting-edge technologies and advancing its product portfolio. These milestones demonstrate the company's dedication to delivering value to its customers and shareholders, solidifying its position as a leading player in the healthcare industry.

Central China New Life Ltd (CCNL) is a renowned company operating in the industry of pharmaceuticals and healthcare products. Established in 1998, CCNL has grown to become a leading provider of traditional Chinese medicine solutions, focusing on the research, development, production, and distribution of therapeutic products. With a commitment to innovation and quality, CCNL has built a strong reputation both domestically and internationally. The company has achieved significant milestones in its history, expanding its product portfolio and exploring new markets. As a trusted brand in the industry, Central China New Life Ltd continues to contribute to the well-being of individuals through its cutting-edge healthcare solutions.

The main competitors of Central China New Life Ltd in the market include ABC Insurance, XYZ Investments, and DEF Financial Services.

Central China New Life Ltd is primarily active in the healthcare and pharmaceutical industries. The company focuses on the research, development, and production of pharmaceutical products, including traditional Chinese medicine, health food, and medical devices. With a strong presence in the domestic market, Central China New Life Ltd aims to contribute to improving the well-being and quality of life of individuals through its innovative healthcare solutions. As a leader in the industry, Central China New Life Ltd continues to expand its product portfolio and explore new opportunities for growth and development.

The business model of Central China New Life Ltd is focused on the provision of funeral and related services. The company primarily operates funeral homes, cemeteries, and crematories. Central China New Life Ltd offers a range of funeral services including traditional burial, cremation, and memorial services. The company also provides funeral merchandise such as caskets, urns, and grave markers. With a strong focus on serving the local community, Central China New Life Ltd aims to provide compassionate and professional funeral services to honor the memory of the deceased.

Central China New Life KGV ir 4,29.

Central China New Life KUV ir 0,46.

AlleAktien kvalitātes vērtējums Central China New Life ir 3/10.

gaidāmā Central China New Life apgrozījums ir 3,05 miljardi CNY.

gaidāmā Central China New Life peļņa ir 325,13 milj. CNY.

Central China New Life Ltd is a company based in Xiangyang city, Hubei province, China. The company has expanded its business fields since its establishment in 1997 and now offers a wide range of products and services in various sectors. The first sector of Central China New Life Ltd is the healthcare sector. The company has been active in the healthcare sector for over 20 years and offers a wide range of products, including supplements, traditional Chinese medicine, modern medical devices, and services. The company specializes in offering its products and services of the highest quality at an affordable price and places great emphasis on research and development to stay up to date. The second sector is the real estate business. Central China New Life Ltd owns several properties around the world, including in China, Europe, and the USA. The company has extensive experience in developing real estate projects and also offers real estate services such as rental and property management. Another sector is the education business. The company has multiple educational institutions in China and offers a variety of courses, including language courses, traditional Chinese calligraphy and painting courses, as well as courses in computer and information technology. Central China New Life Ltd uses modern technology and methods to provide the best curriculum and instruction. In addition to the mentioned sectors, the company also offers products and services in the e-commerce sector, including e-commerce platforms, online payment services, and logistics. The company has a future-oriented vision for commerce and focuses on the integration of online and offline businesses to provide the best possible customer experience. However, the core business of Central China New Life Ltd remains the healthcare sector. The company aims to be a leading company in the healthcare market and provide its customers with the best products and services. The company places great value on adhering to the best practices and highest standards in the healthcare sector. In recent years, the company has also made significant investments in research and development to continually improve its products and services. Overall, Central China New Life Ltd has become one of the leading companies in China with its wide business fields, extensive experience, and focus on innovation and quality. The company strives to further expand its business sectors and offer new products and services to always meet the needs of its customers and provide them with high added value.

Central China New Life izmaksā dividendes 0,55 CNY, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt Central China New Life vai uzņēmums nedod dividendes.

Central China New Life ISIN ir KYG206AA1025.

Central China New Life simbols ir 9983.HK.

Pēdējo 12 mēnešu laikā Central China New Life maksāja dividendes 0,28 CNY apmērā. Tas atbilst aptuveni 25,46 % dividendes ražībai. Nākamajos 12 mēnešos Central China New Life plāno maksāt dividendes 0,28 CNY apmērā.

Central China New Life pašreizējā dividendu rentabilitāte ir 25,46 %.

Central China New Life maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos oktobris, jūnijs, oktobris, augusts.

Central China New Life pēdējo 11 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0,28 CNY. Tas atbilst dividendes ražībai 25,74 %.

Central China New Life tiek piešķirts nozarei "Nekustamais īpašums".

Lai saņemtu pēdējo dividendu Central China New Life apmērā 0,241 CNY, kas tika izmaksāta 18.07.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 3.07.2024..

Pēdējās dividendes izmaksa notika 18.07.2024..

Gadā 2023, Central China New Life izmaksāja 0,548 CNY dividendes.

Central China New Life dividendes tiek izmaksātas CNY.